Chronic obstructive pulmonary disease and infection: From stable patients to pneumonia

Clinical Pulmonary Medicine

Volumn 6, Issue 1, 1999, Pages 1-8

  Ewig, Santiago ^b   Soler, Néstor ^b   Torres, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Colonization; Microbial patterns; Pneumonia

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; INFLUENZA VACCINE; MACROLIDE; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE; TETRACYCLINE; TOBRAMYCIN;

BACTERIAL COLONIZATION; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; MULTICENTER STUDY; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE;

EID: 0033042164     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199901000-00001     Document Type: Review

References (58)

1. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med 1969; 280:397-404.
2. May JR. The bacteriology of chronic bronchitis. Lancet 1053;2:534-7.
3. Brown CC Jr. Chronic bronchitis and emphysema. Am J Med 1954;17:478-84.
4. Stuart-Harris CH. The role of bacterial and viral infection in chronic bronchitis. Arch Environ Health 1968;16:586-95.
5. Haas H, Morris JF, Samson S, Kilbourn JP, Kim PJ. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbronchoscopic and oropharyngeal sampling methods. Am Rev Respir Dis 1977; 116:41-7.
6. Riise GC, Larsson S, Larrson P, Jeansson S, Andersson BA. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J 1994;7: 94-101.
7. Irwin RS, Erickson AD, Pratter MR, et al. Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis 1982;145:234-41.
8. Monsó E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152: 1316-20.
9. Cabello H, Torres A, Celis R, et al. Distal airway bacterial colonisation in healthy subjects and chronic lung diseases: a bronchoscopic study. Eur Respir J 1997;10:1137-44.
10. Smith CB, Golden CA, Klauber MR, Kanner R, Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976;134:552-61.
11. Deleted in proof.
12. Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995;50:360-5.
13. Anthonisen N, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
14. Saint S, Bent S, Vittinghof E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995;273:957-60.
15. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113:465-74.
16. McHardy VU, Inglis JM, Calder MA. A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest 1980;74: 228-38.
17. Schreiner A, Bkerkestrand G, Digranes A, et al. Bacteriological findings in the transtracheal aspirate from patients with acute exacerbations of chronic bronchitis. Infection 1978;6: 54-6.
18. Martinez JA, Rodriguez E, Bastida T, Buges J, Torres M. Quantitative study of the bronchial bacterial flora in acute exacerbations of chronic bronchitis [letter]. Chest 1994;105:976.
19. Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal microflora during acute exacerbations of chronic bronchitis. Am Rev Respir Dis 1990;142:1004-8.
20. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505.
21. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. QJM 1995;88:61-8.
22. Francis RS, May JR, Spicer CC. Chemotherapy of bronchitis: influence of penicillin and tetracycline administered daily, or intermittent for exacerbations. BMJ 1961;2:979-85.
23. Francis RS, Spicer CC. Chemotherapy in chronic bronchitis. BMJ 1960;1:297-303.
24. Fletcher CM, Oldham PD. Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the medical research council by their working party on trials on chemotherapy in early chronic bronchitis. BMJ 1960;1:1317-22.
25. Taylor DC, Clancy RL, Cripps AW, Butt H, Bartlett L, Muree-Allen K. An alteration in the host-parasite relationship in subjects with chronic bronchitis prone to recurrent episodes of acute bronchitis. Immunol Cell Biol 1994;72: 143-51.
26. Nicotra B, Rivera M, Luman JI, et al. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986;146:890-3.
27. Beaty CD, Grayston JT, Wang SP, Kuo CC, Reto CS, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;144:1408-10.
28. Blasi F, Legnani D, Lombardo WM, et al. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J 1993;6:19-22.
29. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic obstructive pulmonary disease. Relation between bacteriologic etiology and lung function. Chest 1998;113:1542-8.
30. Buscho LD, Saxtan D, Shultz PS. Respiratory viral infections in hospital patients with chronic bronchitis. Chest 1978;63:336-41.
31. Smith CB, Golden CA, Kanner RE, et al. Association of viral and mycoplasmal infections with respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980;121:225-32.
32. Ewig S, Soler N, Gonzalez J, El-Ebiary M, Celis R, Torres A. Evaluation of antimicrobial treatment in patients with severe exacerbations of chronic obstructive pulmonary disease (COPD). Crit Care Med. In press.
33. Wilson R. The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline. Rev Contemp Pharmacother 1992;3:103-12.
34. Woodhead MA, McFarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671-4.
35. British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 62:195-220.
36. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989;11:586-99.
37. Blanquer J, Blanquer R, Borras R, et al. Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991;46:508-11.
38. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia. Impact of immune status. Am J Respir Crit Care Med 1995;152:1309-15.
39. Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-6.
40. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia in hospitalized patients: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. In press.
41. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community acquired pneumonia. Epidemiology and prognosis factors. Am Rev Respir Dis 1991;114:312-8.
42. British Thoracic Society Research Committee and the Public Health Laboratory Service: the aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir Med 1992;86:7-13.
43. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P, and the French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. Chest 1994;105:1487-95.
44. Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995;107:511-6.
45. Rello J, Rodriguez R, Jubert P, et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin Infect Dis 1996;23:723-8.
46. LaCroix AZ, Lipson S, Miles TP, White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989; 104:350-60.
47. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994;96: 313-20.
48. Torres A, Dorca J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study. Am J Respir Crit Care Med 1996; 154:1456-61.
49. Rodrigues J, Niederman MS, Fein AM, Pai PB. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992;93:29-34.
50. Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. Serious infectious complications of corticoid steroid therapy for COPD. Chest 1989;95:1180-4.
51. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
52. El-Ebiary M, Torres A, Gonzalez J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993;148:1552-7.
53. Marquette CH, Georges H, Wallet F, et al. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993;148:138-44.
54. Timsit JF, Misset B, Azoulay E, Renaud B, Garrouste-Orgeas M, Carlet J. Usefulness of airway visualization in the diagnosis of nosocomial pneumonia in ventilated patients. Chest 1996;110:172-9.
55. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988;93:318-24.
56. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognostic factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-8.
57. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 1995;153:1711-25.
58. Wong CA, Macfarlane JT. Prevention of community-acquired pneumococcal and influenza infection in adults: a re-evaluation of vaccination. Eur Respir Mon 1997;3:56-81.